Facial Rejuvenation Market - By Product Type (Botulinum Toxin, Soft Tissue Fillers, Micro Abrasion Equipment, Chemical Peels, Topical Skin Care Products, and Skin Rejuvenation Devices), By End-User (Hospitals, Dermatology Clinics, and Beauty Centers & Spa), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Description

The global Facial Rejuvenation market is predicted to accrue revenue worth 264.08 (USD Billion) by 2026 and will record the CAGR of nearly 5.2% over the period from 2020 to 2026. The report offers assessment and analysis of the Facial Rejuvenation market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Details of the Report:

Introduction

Facial rejuvenation is a cosmetic therapy that helps in restoration of youthful appearance of the face of human beings. It can be achieved with the help of both surgical and non-surgical methods. Moreover, surgeries can help in restoration of symmetry of face through targeted methods as well as facial restructure & skin alterations. Non-surgical methods helps in addressing of local facial issues like wrinkles, scars, and hyperpigmentation.

Market Growth Dynamics

Easy access to facial treatment along with enhanced consciousness about new techniques will steer the market expansion over the forecast timeline. In addition to this, changing lifestyles has created need for facial rejuvenation methods and this will produce new growth avenues for the market over the forthcoming years. Apparently, rise in the baby boomer population will further propel the demand for the products over the forthcoming years.

Furthermore, rise in the tendency of middle-aged and aged population to look young will proliferate the demand for the facial rejuvenation industry over the forthcoming years. Additionally, increase in the expenditure on facial rejuvenation items will proliferate the market trends over the forthcoming years.  

North America To Lead Overall Market Expansion Over 2020-2026

The expansion of the facial rejuvenation industry in North American sub-continent over the forecast timeline is owing to large-scale acceptance of cost-effective surgical methods in the countries such as the U.S. Furthermore, growing product penetration of the facial rejuvenation items in the region will steer the regional market expansion over the forthcoming years. Citing an instance, nearly 14 million cosmetic minimally invasive surgeries were performed in the U.S. during 2015.

Key players influencing the market include Revance Therapeutics Inc., Contura International A/S, Gal derma S/A, Biopolymer GmbH & Co., Merz GmbH & Co. KGaA, Anika Therapeutics Inc., Mentor Worldwide LLC, Specialty European Pharma, LUMENIS, Cynosure Inc., and Fibrocell Inc.

The global facial rejuvenation market is segmented as follows:

By product type:

• Botulinum Toxin (BOTOX)
• Soft Tissue Fillers
  • Short-term Fillers
  • Medium-term Fillers
  • Long-term Fillers
• Microabrasion Equipment
• Chemical Peels
• Topical Skin Care Products
• Skin Rejuvenation Devices
  • Microdermabrasion
  • Intense Pulsed Light
  • Laser-based Devices
  • Ultrasound

By end-user:

• Dermatology Clinics
• Hospitals
• Beauty Centers & Spa

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Facial Rejuvenation Market, 2016–2026(USD Billion)
  • 2.2. Facial Rejuvenation Market: Snapshot
• Chapter 3. Global Facial Rejuvenation Market– Industry Analysis
  • 3.1. Facial Rejuvenation Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Easy access to facial treatment along with enhanced consciousness about new techniques will drive the growth of facial rejuvenation industry over forthcoming years.
    • 3.2.2. Rise in the tendency of middle-aged and aged population to look young will pruliferate the demand for the facial rejuvenation products over the upcoming years
  • 3.3. Market Attractiveness Analysis
    • 3.3.1. Market attractiveness analysis By End-Users
    • 3.3.2. Market attractiveness analysis By Product Type
• Chapter 4. Global Facial Rejuvenation Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Facial Rejuvenation Market: company market share, 2019
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New End User launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Facial Rejuvenation Market–End Users Analysis
  • 5.1. Global Facial Rejuvenation Market overview: By End Users
    • 5.1.1. Global Facial Rejuvenation Market share, By End Users ,2019 and 2026
  • 5.2. Dermatulogy Clinics
    • 5.2.1. Global Facial Rejuvenation Market by Dermatulogy Clinics, 2016–2026(USD Billion)
  • 5.3. Hospitals
    • 5.3.1. Global Facial Rejuvenation Market by Hospitals, 2016–2026(USD Billion)
  • 5.4. Beauty Centers & Spa
    • 5.4.1. Global Facial Rejuvenation Market by Beauty Centers & Spa, 2016–2026(USD Billion)
• Chapter 6. Global Facial Rejuvenation Market– Product Type Analysis
  • 6.1. Global Facial Rejuvenation Market overview: By Product Type
    • 6.1.1. Global Facial Rejuvenation Market share, By Product Type ,2019 and 2026
  • 6.2. Botulinum Toxin
    • 6.2.1. Global Facial Rejuvenation Market by Botulinum Toxin, 2016–2026(USD Billion)
  • 6.3. Soft Tissue Fillers
    • 6.3.1. Global Facial Rejuvenation Market by Soft Tissue Fillers, 2016–2026(USD Billion)
  • 6.4. Micro Abrasion Equipment
    • 6.4.1. Global Facial Rejuvenation Market by Micro Abrasion Equipment, 2016–2026(USD Billion)
  • 6.5. Chemical Peels
    • 6.5.1. Global Facial Rejuvenation Market by Chemical Peels, 2016–2026(USD Billion)
  • 6.6. Topical Skin Care Products
    • 6.6.1. Global Facial Rejuvenation Market by Topical Skin Care Products, 2016–2026(USD Billion)
  • 6.7. Skin Rejuvenation Devices
    • 6.7.1. Global Facial Rejuvenation Market by Skin Rejuvenation Devices, 2016–2026(USD Billion)
• Chapter 7. Company Profiles
  • 7.1. Revance Therapeutics Inc.
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Merz GmbH & Co. KGaA
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. Anika Therapeutics Inc.
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. Specialty European Pharma
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Developments
  • 7.5. LUMENIS
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Development
  • 7.6. Cynosure Inc.
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Development
  • 7.7. Mentor Worldwide LLC
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Product Portfolio
    • 7.7.4. Business Strategy
    • 7.7.5. Recent Development
  • 7.8. Biopulymer GmbH & Co.
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Product Portfolio
    • 7.8.4. Business Strategy
    • 7.8.5. Recent Development
  • 7.9. Gal derma S/A
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Product Portfolio
    • 7.9.4. Business Strategy
    • 7.9.5. Recent Development
  • 7.10. Contura International A/S
    • 7.10.1. Overview
    • 7.10.2. Financials
    • 7.10.3. Product Portfolio
    • 7.10.4. Business Strategy
    • 7.10.5. Recent Development
  • 7.11. Fibrocell Inc.
    • 7.11.1. Overview
    • 7.11.2. Financials
    • 7.11.3. Product Portfolio
    • 7.11.4. Business Strategy
    • 7.11.5. Recent Development

Methodology